The availability of Micro-Neighborhood® Targeting on the Company’s Dynamic Audience Activation Platform meets the demand of life sciences marketers by synchronizing consumer and physician marketing

OptimizeRx presents panel session at Digital Pharma East: Unlocking Opportunity through HCP+DTC Alignment in Omnichannel Oncology Marketing

OptimizeRx Corp., a leader in healthcare technology solutions, has announced a significant upgrade to its Dynamic Audience Activation Platform (DAAP) with the introduction of Micro-Neighborhood Targeting (MNT). This cutting-edge AI-driven technology enhances the platform’s ability to deliver synchronized Direct-to-Consumer (DTC) and healthcare professional (HCP) campaigns, aiming to improve patient-physician communication throughout the treatment journey.

1. AI-Driven Innovation in Life Sciences Marketing:

   • Micro-Neighborhood Targeting (MNT): A key feature of DAAP, MNT utilizes AI to predict brand eligibility and precisely time point-of-care messaging for treating HCPs. This approach aims to optimize the delivery of brand communications to the most relevant audiences.
   • Dynamic Precision Targeting: The platform’s AI learns patterns that predict brand eligibility, enhancing targeting accuracy and achieving better results compared to traditional methods.

2. Enhanced Campaign Coordination:

   • Unified DTC and HCP Campaigns: The integration of brand eligibility signals with MNT allows for synchronized campaigns that reach both healthcare consumers and providers effectively.
   • Real-World Data (RWD) Utilization: DAAP leverages advanced machine learning models and RWD to deploy personalized, relevant communications across various digital media channels, including TV, programmatic display, video, social media, and streaming radio.

3. Impact and Benefits:

   • Improved Campaign Performance: DAAP has demonstrated a 25% average script lift in HCP audiences over the past three years. The alignment of DTC and HCP marketing efforts is shown to streamline care and improve patient outcomes.
   • Privacy-Compliant Solutions: OptimizeRx’s platform prioritizes privacy by connecting physician and patient audiences in compliance with stringent privacy standards, using patented methods that enhance audience targeting without relying on traditional tokens.

4. Industry Insights and Future Outlook:

   • Client Trust and Value: Over 300 leading pharmaceutical brands rely on OptimizeRx for superior audience quality, data-rich insights, and cost-effective marketing solutions.
   • Panel Session at Digital Pharma East: Join OptimizeRx on September 11, 2024, at 9:45am for a panel session titled "Unlocking Opportunity through HCP+DTC Alignment in Omnichannel Oncology Marketing" to explore the benefits of healthcare audience alignment.

OptimizeRx’s new Micro-Neighborhood Targeting (MNT) feature on the Dynamic Audience Activation Platform (DAAP) represents a major advancement in healthcare marketing. By synchronizing DTC and HCP campaigns through AI-driven predictive targeting, OptimizeRx aims to bridge the communication gap between patients and physicians, enhancing the overall effectiveness of marketing efforts and improving patient care.